• 1. Breast Disease Center of West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
  • 2. Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China;
  • 3. Department of Oncologic Plastic Surgery, Hunan Cancer Hospital, Changsha, 410013, P. R. China;
  • 4. Department of Breast Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing, 100020, P. R. China;
  • 5. Breast Surgery Department, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China;
  • 6. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China;
DU Zhenggui, Email: docduzg@163.com; Lü Qing, Email: lqlq1963@163.com
Export PDF Favorites Scan Get Citation

Recent research from the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) indicates that breast cancer is the most prevalent malignant tumor among women, posing a significant threat to women's health. Surgery remains the primary therapeutic modality for breast cancer. Recently, endoscopic and robotic breast surgical techniques have gained acceptance among both surgeons and patients. However, considerable variation exists in surgical approaches and outcomes. To standardize these techniques, facilitate their broader clinical adoption, and ultimately improve patient care, the Endoscopic-robotic Breast Surgery Clinical Trials Consortium (ErBSCTC) of China has developed this guideline. This document encompasses the technologies and instrumentation utilized in endoscopic and robotic breast surgery, surgical techniques, perioperative management, complication handling, long-term follow-up, and oncologic outcomes, aiming to provide evidence-based guidance for healthcare professionals involved in the prevention, diagnosis, and treatment of breast diseases.

Citation: DU Zhenggui, Lü Qing, Lü Pengwei, SONG Dajiang, WANG Zihan, YANG Benlong, SU Shicheng, on behalf of the Chinese Endoscopic-robotic Breast Surgery Clinical Trials Consortium (CErBSCTC). Guidelines for endoscopic and robotic breast surgery in China (2026 edition): Part one. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2026, 33(2): 167-203. doi: 10.7507/1007-4848.202512015 Copy

Copyright ? the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved

  • Previous Article

    Liver cancer surgery and the miracles of survival: report of 10 cases
  • Next Article

    Comparison of gastric cancer epidemiological features among China, Japan, and South Korea: based on the GLOBOCAN 2018–2022